Guerbet S (France) Today
| GBT Stock | EUR 26.15 0.20 0.77% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Guerbet S is trading at 26.15 as of the 28th of November 2024, a 0.77% up since the beginning of the trading day. The stock's open price was 25.95. Guerbet S has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Guerbet S A are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Guerbet SA engages in the research, development, production, and sale of contrast media products, delivery systems, medical devices, and related solutions worldwide. Guerbet SA was founded in 1926 and is headquartered in Villepinte, France. GUERBET operates under Medical Devices classification in France and is traded on Paris Stock Exchange. The company has 12.62 M outstanding shares. More on Guerbet S A
Moving against Guerbet Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Guerbet Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Guerbet S's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Guerbet S or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
Guerbet S A (GBT) is traded on Euronext Paris in France and employs 2,730 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 244.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Guerbet S's market, we take the total number of its shares issued and multiply it by Guerbet S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Guerbet S A operates under Healthcare sector and is part of Medical Devices industry. The entity has 12.62 M outstanding shares.
Guerbet S A has accumulated about 106.76 M in cash with 115.97 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.5.
Check Guerbet S Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Guerbet S is €244.08 Million. Guerbet S secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Check Guerbet Ownership Details
Guerbet S A Risk Profiles
Although Guerbet S's alpha and beta are two of the key measurements used to evaluate Guerbet S's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.63 | |||
| Standard Deviation | 2.42 | |||
| Variance | 5.85 | |||
| Risk Adjusted Performance | (0.11) |
Guerbet Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Guerbet S without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Guerbet S Corporate Management
Elected by the shareholders, the Guerbet S's board of directors comprises two types of representatives: Guerbet S inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guerbet. The board's role is to monitor Guerbet S's management team and ensure that shareholders' interests are well served. Guerbet S's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guerbet S's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Francois Nicolas | RI RD | Profile | |
| Jerome Estampes | CFO Licensing | Profile | |
| Charlotte Bamiere | G Counsel | Profile | |
| Petra Zalabak | Sr Responsibility | Profile | |
| Philippe Bourrinet | Medical Devel | Profile | |
| JeanFrancois Blanc | VP Imaging | Profile | |
| David Hale | MD CEO | Profile |
Other Information on Investing in Guerbet Stock
Guerbet S financial ratios help investors to determine whether Guerbet Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guerbet with respect to the benefits of owning Guerbet S security.